CA Patent

CA3024448C — Modulatory polynucleotides

Assigned to Voyager Therapeutics Inc · Expires 2025-09-09 · 1y expired

What this patent protects

The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of modulatory polynucleotides.

USPTO Abstract

The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of modulatory polynucleotides.

Drugs covered by this patent

Qalsody (TOFERSEN) · Biogen Ma

Patent Metadata

Patent number: CA3024448C
Jurisdiction: CA
Classification: —
Expires: 2025-09-09
Drug substance claim: No
Drug product claim: No
Assignee: Voyager Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.